Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases 40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing...
Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To Australia
OXFORD, England, Feb. 27, 2026 /PRNewswire/ -- Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for the Virtual Nodule Clinic (VNC) platform to support early lung cancer diagnosis. This important regulatory milestone was...
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
Highlights: First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001 for the treatment of ALS Approximately 160 participants with ALS will be enrolled in a 36-week randomised, double-blind, placebo-controlled adaptive Phase 2/3 clinical trial in leading ALS clinical centres across the United States Follows a successful Phase 1 clinical...
ArisGlobal Launches NavaX Translation to Eliminate Manual Translation in Global Pharmacovigilance
Strategic partnership with TransPerfect Life Sciences embeds certified, pharma-grade translation directly into LifeSphere Safety workflows BOSTON, Feb. 26, 2026 /PRNewswire/ -- ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, recently announced the launch of NavaX Translation, a new solution delivered through a strategic partnership with TransPerfect Life Sciences. NavaX...
SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union
SK–IDT–Vaxxas consortium establishes strategic entry point for high-density microarray patch (HD-MAP) vaccines in Europe to improve vaccine performance and access. Parallel development of high-immunogenicity HD-MAP vaccines for seasonal and pandemic influenza threats. INCHEON, South Korea, Feb. 26, 2026 /PRNewswire/ -- SK bioscience announced that, together with IDT Biologika (IDT) and...
CJ BIO Publishes Clinical Study on BiomeNrich™ POST SZ075, a Postbiotic Ingredient Demonstrating Skin Improvement Benefits
SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ -- CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed journal. The study strengthens the scientific foundation of the ingredient and supports its positioning as a science-based inner beauty solution. BiomeNrich POST SZ075,...
HealthTech Partners Global Expands Clinical Education Division and Appoints Strategic Advisor Rusty Page Under Leadership of Former DIH Commercial VP Allison Krumpe
RICHMOND, Va., Feb. 26, 2026 /PRNewswire/ -- HealthTech Partners Global today announced a major expansion of its international clinical education division, alongside the appointment of strategic advisor Rusty Page, whose expertise in operations, quality, and IT will strengthen the company's global infrastructure. Under the leadership of former DIH Commercial Vice President of...
Health Awareness Week Underscores the Importance of Respiratory Health
NEW YORK, Feb. 26, 2026 /PRNewswire/ -- As Health Awareness Week brings focus to preventive care and chronic condition management, VARON is highlighting the vital role respiratory health plays in overall well-being. Through its "Your Health, Our Commitment" initiative, the company is promoting greater awareness of breathing health while expanding access to supportive...
genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model
LYON, France, Feb. 26, 2026 /PRNewswire/ -- Antibody therapies are changing the treatment of cancer, inflammatory diseases and infections. However, many promising drug candidates fail in clinical trials. A study in Science Immunology shows that genOway's genO-hFcγR mouse model enables more accurate prediction of therapeutic antibody efficacy and safety. genOway:...
BC30™ Approved for “Live Culture” Claim in Indonesia, Opening Opportunities in F&B Innovation
JAKARTA, Indonesia, Feb. 26, 2026 /PRNewswire/ -- Kerry's BC30™ (Bacillus coagulans GBI‑30, 6086), a resilient, spore‑forming probiotic ingredient, has received regulatory approval in Indonesia for use with the "Live Culture" claim across applicable general food categories. The approval follows the inclusion of BC30™ in Indonesia's permitted microorganism list under PERBPOM No. 38/2023, which...
